GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
7EKG | Q9BYF1 | Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 | |
7EKG | P0DTC2 | Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 | |
7XU5 | P0DTC2 | Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation | |
7XU4 | P0DTC2 | Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation | |
7WNM | P0DTC2 | Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q) | |
7WNM | Q9BYF1 | Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q) | |
7EKC | Q9BYF1 | Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 | |
7EKC | P0DTC2 | Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 | |
7XMN | A0A376KDN7 | Structure of SARS-CoV-2 ORF8 | |
7XMN | P0DTC8 | Structure of SARS-CoV-2 ORF8 | |
8F0G | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 | |
8F0G | 8F0G | Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 | |
8DZI | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZI | 8DZI | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZH | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZH | 8DZH | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8H5C | Q9BYF1 | Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 | |
8H5C | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 | |
7LCN | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1 | |
7LCN | 7LCN | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1 | |
7LAB | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
7LAB | 7LAB | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
7LAA | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
7LAA | 7LAA | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
7LD1 | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 | |
7LD1 | 7LD1 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 | |
7MTE | P0DTC2 | Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment | |
6ZP1 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State | Matrix protein 1 |
6ZP2 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State | |
6ZP0 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State | Matrix protein 1 |
7XU3 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation | |
7XTZ | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation | |
7XU1 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation | |
7XU2 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation | |
7XU0 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation | |
7XU6 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation | |
8IOV | Q9BYF1 | Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 | |
8IOV | P0DTC2 | Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 | |
8IOU | P0DTC2 | Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) | |
8IOU | Q9BYF1 | Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) | |
8JYP | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 | |
8JYP | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 | |
8JYN | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) | |
8JYN | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) | |
8JYO | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) | |
8JYO | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) | |
7XSW | 7XSW | Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD | |
7XSW | A0A6G6A2Q2 | Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD | |
6VW1 | Q9BYF1 | Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 | |
6VW1 | P59594 | Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024